Literature DB >> 33419562

The role of the tyrosine kinase Lyn in allergy and cancer.

Yizhao Sun1, Yanlei Yang1, Yang Zhao1, Xiangsheng Li1, Yanfen Zhang2, Zhongcheng Liu3.   

Abstract

With worsening air pollution brought by global social development, the prevalence of allergic diseases has increased dramatically in the past few decades. The novel Lck/yes-related protein tyrosine kinase (Lyn) belongs to the Src kinase family (SFK) and plays a pivotal role in the pathogenesis of inflammation, tumor, and allergy. This signaling molecule is vital in the IgE/FcεRI signaling pathway that regulates allergy. The Lyn-FcεRIβ interaction is essential for mast cell activation. The signaling pathway of Lyn has become the focus of immune, inflammatory, tumor, and allergy research. This molecule has positive and negative regulatory effects, which have attracted researchers' attention. This paper reviews the basic characteristics of Lyn and its regulatory mechanism and role in tumor and other diseases, specifically in allergies.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Allergic diseases; Lyn; Regulatory mechanism

Year:  2021        PMID: 33419562     DOI: 10.1016/j.molimm.2020.12.028

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

Review 1.  O-GlcNAcylation and Its Role in Cancer-Associated Inflammation.

Authors:  Muzi Ouyang; Changmeng Yu; Xiaolian Deng; Yingyi Zhang; Xudong Zhang; Fangfang Duan
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

2.  Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9.

Authors:  Jiawei Liu; Jing Li; Haolin Du; Liming Xu; Zhenbang Yang; Mengjiao Yuan; Kaiyue Zhang; Jialei Li; Wenjun Xing; Shoujie Wang; Tingting Hu; Jinjin Wang; Jin Wang; Qian Gong
Journal:  Comput Math Methods Med       Date:  2022-01-22       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.